Skip to content

Group News

Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Jul 28, 2022

Durban – JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This declaration is the first since that announced…

Read More >>

Aspen hosts more than 800 Mandela Day activities over 12 years

Jul 18, 2022

“Our purpose, To improve the health and quality of life of patients is closely aligned to the ethos of Mandela Day. This has been clearly demonstrated through our endeavours to provide citizens across the continent with vaccines which are manufactured in South Africa for Africa.”   Durban – JSE Limited listed Aspen Pharmacare Holdings Limited…

Read More >>

Aspen donates life-saving surgical anaesthetics for about 240 000 Lebanese patients

Jun 20, 2022

Aspen’s donation of anaesthetics to Lebanese patients   Johannesburg, South Africa – Aspen Global Incorporated, a subsidiary of Pharmacare Limited, Africa’s largest pharmaceutical company, has donated a second supply of life-saving anaesthetics to Lebanon to facilitate surgical interventions to treat an additional 79 000 patients. This donation follows on Aspen’s donation of anaesthetics and oncology products…

Read More >>

Aspen presented with prestigious SAIC Business Award

Mar 25, 2022

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company was honoured at the 4th South African Investment Conference (“SAIC”) when it was presented with an award, by South African President Mr Cyril Ramaphosa, recognising Companies that Best Responded to the Challenges of the COVID Environment. The award acknowledges the role that…

Read More >>

Aspen announces R500 million investment at 4th SAIC

Mar 24, 2022

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha.   The announcement comes in the wake of more than R8 billion which Aspen has already invested in this world…

Read More >>

Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Mar 23, 2022

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further demonstrates Aspen’s ongoing commitment to saving lives and improving the quality of life of patients irrespective of their location or circumstances. Stavros Nicolaou Aspen Senior Executive…

Read More >>

Aspen helps evacuate SA students stranded in the Ukraine

Mar 10, 2022

Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International Relations and Cooperation (“DIRCO”) to assist in the emergency evacuation of South African students who have been studying at various Universities…

Read More >>

Aspen delivers double digit organic revenue grown in constant exchange rates

Mar 9, 2022

  Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2021. SALIENT RESULTS Aspen reported the following salient results: Revenue from continuing operations increased by 4% (+10% in constant exchange rate (“CER”) to R19,4 billion…

Read More >>

Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa

Mar 8, 2022

“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.

Read More >>

Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Feb 12, 2022

Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and Department of International Relations and Cooperations’ (“DIRCO”) Ubuntu Award in the Economic Diplomacy (Global) category at its prestigious 6th annual awards ceremony hosted in Cape Town for this purpose. This…

Read More >>

CONTACT DETAILS

Shauneen Beukes
Group Communications Manager
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Scroll To Top